Targeting protein prenylation for cancer therapy

Berndt, Norbert, Hamilton, Andrew D., Sebti, Saïd M.·2011·Nature Reviews Cancer

DOI 10.1038/nrc3151

Cited by (622)

Items 201–300 of 622

CXCL12 in Pancreatic Cancer: Its Function and Potential as a Therapeutic Drug Target
Shivani Malik, Jill M. Westcott, Rolf A. Brekken, Francis J. Burrows · 2021 · Cancers
The KLK5 protease suppresses breast cancer by repressing the mevalonate pathway
Georgios Pampalakis, Osahon Obasuyi, Olga Papadodima, Aristotelis A. Chatziioannou, Vassileios Zoumpourlis, Georgia Sotiropoulou · 2013 · Oncotarget
A shunt pathway limits the CaaX processing of Hsp40 Ydj1p and regulates Ydj1p-dependent phenotypes
Emily R. Hildebrandt, Michael Cheng, Peng Zhao, June H Kim, Lance Wells, Walter K. Schmidt · 2016 · eLife
The impact of melanoma genetics on treatment response and resistance in clinical and experimental studies
Manfred Kunz, Michael Hölzel · 2017 · Cancer and Metastasis Reviews
Emerging Role of Migration and Invasion Enhancer 1 (MIEN1) in Cancer Progression and Metastasis
Prem Prakash Kushwaha, Sanjay Gupta, Atul Kumar Singh, Shashank Kumar · 2019 · Frontiers in Oncology
Hepatitis Delta Virus: Replication Strategy and Upcoming Therapeutic Options for a Neglected Human Pathogen
Florian A. Lempp, Stephan Urban · 2017 · Viruses
Targeting KRASG12C in colorectal cancer: the beginning of a new era
Davide Ciardiello, Brigida Anna Maiorano, Erika Martinelli · 2022 · ESMO Open
Nature's contribution to today's pharmacopeia
Lin Tao, Feng Zhu, Qin Chu, Cheng Zhang, Feng Xu, Chun Yan Tan, Yu Jiang, Yu Chen · 2014 · Nature Biotechnology
Metalloprotein–Inhibitor Binding: Human Carbonic Anhydrase II as a Model for Probing Metal–Ligand Interactions in a Metalloprotein Active Site
David P. Martin, Zachary S. Hann, Seth M. Cohen · 2013 · Inorganic Chemistry
Targeting Mutant KRAS in Pancreatic Cancer: Futile or Promising?
Friederike Inga Nollmann, Dietrich Alexander Ruess · 2020 · Biomedicines
Ubiquitin specific peptidase 32 acts as an oncogene in epithelial ovarian cancer by deubiquitylating farnesyl-diphosphate farnesyltransferase 1
Aya Nakae, Michiko Kodama, Toru Okamoto, Makoto Tokunaga, Hiroko Shimura, Kae Hashimoto, Kenjiro Sawada, Takahiro Kodama, Neal G. Copeland, Nancy A. Jenkins et al. · 2021 · Biochemical and Biophysical Research Communications
Nucleotide based covalent inhibitors of KRas can only be efficient in vivo if they bind reversibly with GTP-like affinity
Matthias Philipp Müller, Sadasivam Jeganathan�, Angelika Heidrich, Jérémy Campos, Roger Sidney Goody · 2017 · Scientific Reports
Pharmacological diversity among drugs that inhibit bone resorption
R.G.G. Russell · 2015 · Current Opinion in Pharmacology
Differences of statin activity in 2D and 3D pancreatic cancer cell cultures
Miglė Paškevičiūtė, Vilma Petrikaitė · 2017 · Drug Design Development and Therapy
Hutchinson-Gilford progeria syndrome: Rejuvenating old drugs to fight accelerated ageing
Solenn M. Guilbert, Déborah Cardoso, Nicolas Lévy, Antoine Muchir, Xavier Nissan · 2020 · Methods
Development of Pyridazinone Chemotypes Targeting the PDEδ Prenyl Binding Site
Sandip Murarka, Pablo Martín‐Gago, Carsten Schultz‐Fademrecht, Alaa Al Saabi, Matthias Baumann, Eyad K. Fansa, Shehab Ismail, Peter Nußbaumer, Alfred Wittinghofer, Herbert Waldmann · 2016 · Chemistry - A European Journal
Signal Transduction: From the Atomic Age to the Post-Genomic Era
Jeremy W. Thorner, Tony Hunter, Lewis C. Cantley, Richard Sever · 2014 · Cold Spring Harbor Perspectives in Biology
Discovery of Novel KRAS-PDEδ Inhibitors by Fragment-Based Drug Design
Chen, Long, Zhuang, Chunlin, Lu, Junjie, Jiang, Yan, Sheng, Chunquan · 2018 · Journal of Medicinal Chemistry
An early clinical trial of Salirasib, an oral RAS inhibitor, in Japanese patients with relapsed/refractory solid tumors
Junji Furuse, Takayasu Kurata, Naohiro Okano, Yasuhito Fujisaka, Daisuke Naruge, Toshio Shimizu, Hiroshi Kitamura, Tsutomu Iwasa, Fumio Nagashima, Kazuhiko Nakagawa · 2018 · Cancer Chemotherapy and Pharmacology
Current and Future Management of Chronic Hepatitis D.
Patrizia Farci, Grazia Anna Niro · 2018 · Europe PMC (PubMed Central)
From Genetic Alterations to Tumor Microenvironment: The Ariadne’s String in Pancreatic Cancer
Chiara Bazzichetto, Fabiana Conciatori, Claudio Luchini, Francesca Simionato, Raffaela Santoro, Vanja Vaccaro, Vincenzo Corbo, Italia Falcone, Gianluigi Ferretti, Francesco Cognetti et al. · 2020 · Cells
A combination of metabolic labeling and 2D-DIGE analysis in response to a farnesyltransferase inhibitor facilitates the discovery of new prenylated proteins
Charuta C. Palsuledesai, Joshua D. Ochocki, Todd W. Markowski, Mark Dewey Distefano · 2014 · Molecular BioSystems
Structural Biology-Inspired Discovery of Novel KRAS–PDEδ Inhibitors
Jiang, Yan, Zhuang, Chunlin, Chen, Long, Lu, Junjie, Dong, Guoqiang, Miao, Zhenyuan, Zhang, Wannian, Li, Jian, Sheng, Chunquan · 2017 · Journal of Medicinal Chemistry
Bi-allelic Variants in RALGAPA1 Cause Profound Neurodevelopmental Disability, Muscular Hypotonia, Infantile Spasms, and Feeding Abnormalities
Wagner, Matias, Skorobogatko, Yuliya, Pode-Shakked, Ben, Powell, Cynthia M., Alhaddad, Bader, Seibt, Annette, Barel, Ortal, Heimer, Gali, Hoffmann, Chen, Demmer, Laurie A. et al. · 2020 · The American Journal of Human Genetics
Gastric cancer cell death analyzed by live cell imaging of spheroids
George Alzeeb, Danielle Arzur, Valérie Trichet, Matthieu Talagas, Laurent Corcos, Catherine Le Jossic-Corcos · 2022 · Scientific Reports
Glutamine, Glucose and other Fuels for Cancer
María Victoria Ruiz-Pérez, Francisca Sánchez‐Jiménez, Francisco José Alonso, Juan Segura, Javier Márquez, Miguel Ángel Medina · 2014 · Current Pharmaceutical Design
RAS Function in cancer cells: translating membrane biology and biochemistry into new therapeutics
Walaa E. Kattan, John F. Hancock · 2020 · Biochemical Journal
Is there a future for prenyltransferase inhibitors in cancer therapy?
Sarah A. Holstein, Raymond J. Hohl · 2012 · Current Opinion in Pharmacology
K-Ras4B/calmodulin/PI3Kα: A promising new adenocarcinoma-specific drug target?
Ruth Nussinov, Serena Muratcioğlu, Chung‐Jung Tsai, Hyunbum Jang, Attila Gürsoy, Özlem Keskin · 2015 · Expert Opinion on Therapeutic Targets
The RAL signaling network: Cancer and beyond
Lisa Helene Apken, Andrea Oeckinghaus · 2020 · International review of cytology
Splice switching an oncogenic ratio of SmgGDS isoforms as a strategy to diminish malignancy
Anthony C. Brandt, Lisa M. McNally, Ellen Lorimer, Bethany Unger, Olivia J. Koehn, Kiall F. Suazo, Lisa Rein, Anikó Szabó, Shirng‐Wern Tsaih, Mark Dewey Distefano et al. · 2020 · Proceedings of the National Academy of Sciences
Pharmacophore Mapping of Thienopyrimidine-Based Monophosphonate (ThP-MP) Inhibitors of the Human Farnesyl Pyrophosphate Synthase
Jaeok Park, Chun Yuen Leung, Alexios N. Matralis, Cyrus M. Lacbay, Michail Tsakos, Guillermo Fernández de Trocóniz, Albert Marinus Berghuis, Youla S. Tsantrizos · 2017 · Journal of Medicinal Chemistry
Inhibition of the mevalonate pathway enhances cancer cell oncolysis mediated by M1 virus
Jiankai Liang, Li Guo, Kai Li, Xiao Xiao, Wenbo Zhu, Xiaoke Zheng, Jun X. Hu, Haipeng Zhang, Jing Cai, Yaya Yu et al. · 2018 · Nature Communications
The Biomedical Importance of the Missing Pathway for Farnesol and Geranylgeraniol Salvage
Ignasi Bofill Verdaguer, Marcell Crispim, Agustín Hernández, Alejandro Miguel Katzin · 2022 · Molecules
Geranylgeranyl diphosphate synthase: Role in human health, disease and potential therapeutic target
Molly E. Muehlebach, Sarah A. Holstein · 2023 · Clinical and Translational Medicine
Cellular FRET-Biosensors to Detect Membrane Targeting Inhibitors of N-Myristoylated Proteins
Arafath Kaja Najumudeen, Monika Köhnke, Maja Šolman, Kirill A. Alexandrov, Daniel Abankwa · 2013 · PLoS ONE
Farnesyltransferase inhibitor tipifarnib inhibits Rheb prenylation and stabilizes Bax in acute myelogenous leukemia cells
Husheng Ding, J. S. McDonald, Seongseok Yun, P. A. Schneider, Kevin L. Peterson, Karen S. Flatten, David A. Loegering, Ann L. Oberg, Shaun M. Riska, Shenglin Huang et al. · 2013 · Haematologica
Targeting energy metabolism to eliminate cancer cells
S. H. Shahruzaman, Sharida Fakurazi, Sandra Maniam · 2018 · Cancer Management and Research
Metabolic Regulation of Human Pluripotent Stem Cell-Derived Cardiomyocyte Maturation
Christopher A. P. Batho, Richard J. Mills, James E. Hudson · 2020 · Current Cardiology Reports
Biology, pathology, and therapeutic targeting of RAS
Joshua Matthew Rhett, Imran Khan, John P. O’Bryan · 2020 · Advances in cancer research
Targeting Mast Cells in Allergic Disease: Current Therapies and Drug Repurposing
Jason R. Burchett, Jordan M. Dailey, Sydney Ann Kee, Destiny T. Pryor, Aditya Kotha, Roma A. Kankaria, David B. Straus, John Jake Ryan · 2022 · Cells
Calcium Carbonate Mineralized Nanoparticles as an Intracellular Transporter of Cytochrome c for Cancer Therapy
Ahn Na Koo, Kyung Hyun Min, Hong Jae Lee, Jun Ho Jegal, Jae Won Lee, Sang Cheon Lee · 2015 · Chemistry - An Asian Journal
A Historic Perspective and Overview of H-Ras Structure, Oncogenicity, and Targeting
Lihua Shu, Dongsheng Wang, Nabil F. Saba, Zhuo G. Chen · 2020 · Molecular Cancer Therapeutics
A CRISPR-Cas9 repressor for epigenetic silencing of KRAS
Jingwen Liu, Meiyan Sun, Kwang Bog Cho, Xiang Gao, Bin Guo · 2020 · Pharmacological Research
Differential Effects of Lovastatin on Cisplatin Responses in Normal Human Mesothelial Cells versus Cancer Cells: Implication for Therapy
Yandong Shi, Emanuela Felley‐Bosco, Thomas M. Marti, Rolf Arno Stahel · 2012 · PLoS ONE
Geranylgeranyl transferase regulates CXC chemokine formation in alveolar macrophages and neutrophil recruitment in septic lung injury
Zirak Hasan, Milladur Rahman, Karzan Palani, Ingvar Syk, Bengt W. Jeppsson, Henrik Thorlacius · 2012 · American Journal of Physiology-Lung Cellular and Molecular Physiology
Structure-based development of PDEδ inhibitors
Pablo Martín‐Gago, Eyad K. Fansa, Alfred Wittinghofer, Herbert Waldmann · 2016 · Biological Chemistry
Current status of the development of Ras inhibitors
Fumi Shima, Shigeyuki Matsumoto, Yoko Yoshikawa, Takashi Kawamura, Masayuki Isa, Tohru Kataoka · 2015 · The Journal of Biochemistry
Treatment of hepatitis D: an unmet medical need
Gian Paolo Caviglia, M. Rizzetto · 2020 · Clinical Microbiology and Infection
Chemical Biology Tools for Regulating RAS Signaling Complexity in Space and Time
Hilde van Hattum, Herbert Waldmann · 2014 · Chemistry & Biology
Developments in Mirna Gene Signaling Pathways in Pancreatic Cancer
Christina Vorvis, Μαρίνα Κουτσιούμπα, Dimitrios Iliopoulos · 2016 · Future Oncology
The Primary Effect on the Proteome of ARID1A-mutated Ovarian Clear Cell Carcinoma is Downregulation of the Mevalonate Pathway at the Post-transcriptional Level
Aaron R. Goldman, Benjamin Guy Bitler, Zachary T. Schug, Jose Ramon Conejo-Garcia, Rugang Zhang, David W. Speicher · 2016 · Molecular & Cellular Proteomics
The spatiotemporal regulation of RAS signalling
Ana Herrero, David Matallanas, Walter Kölch · 2016 · Biochemical Society Transactions
Antifungal Drugs: The Current Armamentarium and Development of New Agents
Nicole Robbins, Gerard D. Wright, Leah E. Cowen · 2017 · ASM Press eBooks
The mevalonate pathway in breast cancer biology
Andy Göbel, Romy M. Riffel, Lorenz Christian Hofbauer, Tilman D. Rachner · 2022 · Cancer Letters
Small molecule inhibitors of RAS proteins with oncogenic mutations
Zoltán Orgován, György Miklós Keserű · 2020 · Cancer and Metastasis Reviews
CRISPR/Cas9 genome-wide loss-of-function screening identifies druggable cellular factors involved in sunitinib resistance in renal cell carcinoma
Peter B. Makhov, Ji A. Sohn, Ilya G. Serebriiskii, Rushaniya Fazliyeva, Vladimir Khazak, Yanis Boumber, Robert G. Uzzo, Vladimir M. Kolenko · 2020 · British Journal of Cancer
Pan-RAS inhibitors: Hitting multiple RAS isozymes with one stone
Alexander B. Coley, Antonio Ward, Adam B. Keeton, Xi Chen, Yulia Y. Maxuitenko, Aishwarya Prakash, Feng Li, Jeremy B. Foote, Donald J. Buchsbaum, Gary Anthony Piazza · 2022 · Advances in cancer research
Crosstalk between Bcl-2 family and Ras family small GTPases: potential cell fate regulation?
Jia Kang, Shazib Pervaiz · 2013 · Frontiers in Oncology
Vibrational Stark effect spectroscopy reveals complementary electrostatic fields created by protein–protein binding at the interface of Ras and Ral
David M. Walker, Ellen C. Hayes, Lauren J. Webb · 2013 · Physical Chemistry Chemical Physics
Molecular mechanisms linking geranylgeranyl diphosphate synthase to cell survival and proliferation
Sherry S. Agabiti, Yilan Liang, Andrew J. Wiemer · 2016 · Molecular Membrane Biology
Targeting the Host for New Therapeutic Perspectives in Hepatitis D
Vincent Turon‐Lagot, Antonio Saviano, Catherine Schuster, Thomas F. Baumert, Eloi Rémi Verrier · 2020 · Journal of Clinical Medicine
Mevalonate Blockade in Cancer Cells Triggers CLEC9A+ Dendritic Cell-Mediated Antitumor Immunity
Feifei Xu, Zining Wang, Hongxia Zhang, Jiemin Chen, Xiaojuan Wang, Lei Cui, Chunyuan Xie, Mengyun Li, Fang Wang, Penghui Zhou et al. · 2021 · Cancer Research
Basics of Radiation Therapy
Elaine M. Zeman, Eric C. Schreiber, Joel E. Tepper · 2020 · Elsevier eBooks
Anti-cancer effects of nitrogen-containing bisphosphonates on human cancer cells
Pengfei Jiang, Peiying Zhang, Rajesh Mukthavaram, Natsuko Nomura, Sandeep C. Pingle, Dayu Teng, Shu Chien, Fang Guo, Santosh Kesari · 2016 · Oncotarget
Tipifarnib prevents development of hypoxia-induced pulmonary hypertension
Lucie Duluc, Blerina Ahmetaj‐Shala, Jane A. Mitchell, Vahitha B. Abdul‐Salam, Abdul S. Mahomed, Lulwah Aldabbous, Eduardo Oliver, Lucio Iannone, Olivier D. Dubois, Elisabeth M. Storck et al. · 2017 · Cardiovascular Research
Statin-induced depletion of geranylgeranyl pyrophosphate inhibits cell proliferation by a novel pathway of Skp2 degradation
Jonathan Vosper, Alessia Masuccio, Michael Keith Kullmann, Christian Ploner, Stephan Geley, Ludger Hengst · 2014 · Oncotarget
Pharmacological modulation of oncogenic Ras by natural products and their derivatives: Renewed hope in the discovery of novel anti-Ras drugs
Shun Ying Quah, Michelle Siying Tan, Yuan Han Teh, Johnson Stanslas · 2016 · Pharmacology & Therapeutics
Significance of Ras Signaling in Cancer and Strategies for its Control
Arun Bahadur Gurung, Atanu Bhattacharjee, Researcher · 2015 · touchREVIEWS in Oncology & Haematology
Novel Antigen Targets for Immunotherapy of Acute Myeloid Leukemia
Meghali Goswami, Christopher Simon Hourigan · 2015 · Current Drug Targets
A recombinant chimeric protein specifically induces mutant KRAS degradation and potently inhibits pancreatic tumor growth
Pan, Ting, Zhang, Yiwen, Zhou, Nan, He, Xin, Chen, Cancan, Liang, Liting, Duan, Xiaobing, Lin, Yingtong, Wu, Kang, Zhang, Hui · 2016 · Oncotarget
The Role of Geranylgeranyltransferase I-Mediated Protein Prenylation in the Brain
Shangfeng Gao, Rutong Yu, Xiuping Zhou · 2015 · Molecular Neurobiology
Annona senegalensis extract demonstrates anticancer properties in N-diethylnitrosamine-induced hepatocellular carcinoma in male Wistar rats
Omolara Faith Yakubu, Damilohun Samuel Metibemu, Isaacson B. Adelani, Gbolahan O. Adesina, Chidera B. Edokwe, Oyinkansola E. Oseha, Abiodun Humphrey Adebayo · 2020 · Biomedicine & Pharmacotherapy
Identification of HMGCR as the anticancer target of physapubenolide against melanoma cells by in silico target prediction
Hai-yan Wang, Pian Yu, Xisha Chen, Hui Wei, Shijie Cao, Meng Zhang, Yi Zhang, Yongguang Tao, Dongsheng Cao, Feng Qiu et al. · 2021 · Acta Pharmacologica Sinica
Prenyltransferases Regulate CD20 Protein Levels and Influence Anti-CD20 Monoclonal Antibody-mediated Activation of Complement-dependent Cytotoxicity
Magdalena Winiarska, Dominika Nowis, Jacek Bil, Eliza Głodkowska‐Mrówka, Angelika Muchowicz, Małgorzata Wańczyk, Kamil Bojarczuk, Michal Dwojak, Małgorzata Firczuk, Ewa Wilczek et al. · 2012 · Journal of Biological Chemistry
Chemical proteomics: a powerful tool for exploring protein lipidation
Elisabeth M. Storck, Remigiusz Adam Serwa, Edward W. Tate · 2013 · Biochemical Society Transactions
Induction of N-Ras degradation by flunarizine-mediated autophagy
Ze-Yi Zheng, Jing Li, Fuhai Li, Yanqiao Zhu, Kemi Cui, Stephen T. C. Wong, Eric C. Chang, Yi‐Hua Liao · 2018 · Scientific Reports
Rac GTPases in Hematological Malignancies
Valerie Durand-Onaylı, Theresa Haslauer, Andrea Härzschel, Tanja Nicole Hartmann · 2018 · International Journal of Molecular Sciences
HSF1 Regulates Mevalonate and Cholesterol Biosynthesis Pathways
Hye-Ji Kang, Taerim Oh, Young Yil Bahk, Geon-Hee Kim, Sang-Yeon Kan, Dong Hoon Shin, Ji Hyung Kim, Ji-Hong Lim · 2019 · Cancers
Systems biology analysis of publicly available transcriptomic data reveals a critical link between AKR1B10 gene expression, smoking and occurrence of lung cancer
Juan Manuel Cubillos-Angulo, Eduardo Rocha Fukutani, Luís A. B. Cruz, María B. Arriaga, João Victor Lima, Bruno B. Andrade, Artur T. L. Queiroz, Kiyoshi F. Fukutani · 2020 · PLoS ONE
Pancreatic cancer, treatment options, and GI-4000
Marion L. Hartley, Najeebah A. Bade, Petra Prins, Leonel Ampie, John Lindsay Marshall · 2014 · Human Vaccines & Immunotherapeutics
Emerging RAS-directed therapies for cancer
Michael R. Conroy, Darren Cowzer, Walter Kölch, Austin G. Duffy · 2021 · Cancer Drug Resistance
Tumor Glucose and Fatty Acid Metabolism in the Context of Anthracycline and Taxane-Based (Neo)Adjuvant Chemotherapy in Breast Carcinomas
Anna‐Mária Tõkés, Stefan Vári-Kakas, Janina Kulka, Beáta Törőcsik · 2022 · Frontiers in Oncology
Emerging trends in post-translational modification: Shedding light on Glioblastoma multiforme
Smita Kumari, Rohan V. Gupta, Rashmi K. Ambasta, Pravir Kumar · 2023 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
Expansion of Protein Farnesyltransferase Specificity Using “Tunable” Active Site Interactions
James L. Hougland, Soumyashree A. Gangopadhyay, Carol A. Fierke · 2012 · Journal of Biological Chemistry
Inhibitors of protein geranylgeranyltransferase-I lead to prelamin A accumulation in cells by inhibiting ZMPSTE24
Sandy Y. Chang, Sarah E. Hudon, Shao Hua Yang, Hea-Jin Jung, John Michael Lee, Emily Farber, Thangaiah Subramanian, Douglas Andres, H. Peter Spielmann, Christine A. Hrycyna et al. · 2012 · Journal of Lipid Research
Diazirine-Containing Photoactivatable Isoprenoid: Synthesis and Application in Studies with Isoprenylcysteine Carboxyl Methyltransferase
Jeffrey S. Vervacke, Amy L. Funk, Yen-Chih Wang, Mark Strom, Christine A. Hrycyna, Mark Dewey Distefano · 2014 · The Journal of Organic Chemistry
SmgGDS-558 regulates the cell cycle in pancreatic, non-small cell lung, and breast cancers
Nathan J. Schuld, Andrew D. Hauser, Adam J. Gastonguay, Jessica M. Wilson, Ellen Lorimer, Carol L. Williams · 2014 · Cell Cycle
Inhibition of isoprenylation synergizes with MAPK blockade to prevent growth in treatment‐resistant melanoma, colorectal, and lung cancer
Nicholas Theodosakis, Casey G. Langdon, Goran Micevic, Irina Krykbaeva, Robert E. Means, David F. Stern, Marcus Bosenberg · 2018 · Pigment Cell & Melanoma Research
Simvastatin enhances chemotherapy in cervical cancer via inhibition of multiple prenylation‐dependent GTP ases‐regulated pathways
Qin Pan, Jiazhen Xu, Liang Ma · 2019 · Fundamental and Clinical Pharmacology
Concurrent Inhibition of ERK and Farnesyltransferase Suppresses the Growth of HRAS Mutant Head and Neck Squamous Cell Carcinoma
Sehrish Javaid, Antje Schaefer, Craig M. Goodwin, Victoria V. Nguyen, Frances L. Massey, Mariaelena Pierobon, Da'Jhnae Gambrell-Sanders, Andrew M. Waters, Kathryn N. Lambert, J. Nathaniel Diehl et al. · 2022 · Molecular Cancer Therapeutics
Guanine nucleotide exchange factors for Rho GTPases (RhoGEFs) as oncogenic effectors and strategic therapeutic targets in metastatic cancer
Rodolfo Daniel Cervantes‐Villagrana, Irving García‐Jiménez, José Vázquez‐Prado · 2023 · Cellular Signalling
The RalGEF/Ral Pathway
Jonathan M. Cooper, Brian O. Bodemann, Michael A. White · 2013 · The Enzymes
Lovastatin prevents cisplatin-induced activation of pro-apoptotic DNA damage response (DDR) of renal tubular epithelial cells
Katharina Krüger, Verena Ziegler, Christina Hartmann, Christian Henninger, Jürgen Thomale, Nicole Schupp, Gerhard Fritz · 2015 · Toxicology and Applied Pharmacology
Protein Isoprenylation in Yeast Targets COOH-Terminal Sequences Not Adhering to the CaaX Consensus
Brittany M. Berger, June H Kim, Emily R. Hildebrandt, Ian C. Davis, Michael C. Morgan, James L. Hougland, Walter K. Schmidt · 2018 · Genetics
Modelling of Protein Kinase Signaling Pathways in Melanoma and Other Cancers
Manfred Kunz, Julio Vera · 2019 · Cancers
The chaperone SmgGDS-607 has a dual role, both activating and inhibiting farnesylation of small GTPases
Desirée García-Torres, Carol A. Fierke · 2019 · Journal of Biological Chemistry
Comprehensive pharmacological profiling of neurofibromatosis cell lines.
Jianman Guo, Michael R. Grovola, Hong Jian Xie, Grace E. Coggins, Patrick Duggan, Rukhsana Nilofer Hasan, Jiale Huang, Danny W. Lin, Claire D. Song, Gabriela M. Witek et al. · 2017 · PubMed Central
The Renaissance of Ras
L.‐G. Milroy, Christian Ottmann · 2014 · ACS Chemical Biology
Targeting KRAS-mutant non-small cell lung cancer: challenges and opportunities
Jun Zhang, Dongkyoo Park, Dong Moon Shin, Xingming Deng · 2015 · Acta Biochimica et Biophysica Sinica